Bachelor of Science, Department of Biotechnology, School of Life Sciences, Peking University
Master of Neuroscience, University of British Columbia, Faculty of Medicine, Canada
Yan Yi’s is primarily involved in researching the mechanism of synaptic plasticity in the nervous system and the pathogenesis of related nervous system diseases. He is also deeply involved in researching the function of Akt in AMPA receptor trafficking and the resulting long-term potentiation (LTP), which can reveal the possible mechanism of Akt action and provide new targets and directions for treating related diseases and drug development. Furthermore, he has studied the mechanism of neuropeptides and their receptors in mediating synaptic plasticity and pain sensitivity in the central nervous system. His research results have brought light on the possible direction to further clarify the pain mechanism. Apart from years of scientific research experience, he has successful experience in running and managing companies, and in building teams and developing corporate culture. He has a strict and disciplined work style, and is highly capable and has excellent communication skills.

Professor, Vice Dean of Institute of Nerve Regeneration and Rehabilitation, Qingdao University, Taishan Scholar
Doctor of Pharmaceutical Chemistry, Academy of Military Medical Sciences
Postdoctoral Fellow in Chemical Biology, University of Toronto, Canada
Professor Dong Mingxin has been engaged in the research and development and production of small molecule and polypeptide drugs for over a decade in the Academy of Military Medical Sciences. He has successfully developed an antiviral small molecule drug which is undergoing phase I clinical trials. He has also completed the preclinical research of one small molecule and two polypeptide candidate drugs. He has published over 20 papers in international scientific journals and has over 10 national invention patents.

Master of Pharmaceutical Chemistry, Fudan University
Geng Chuanrong has previously worked in Shanghai Roche Pharmaceutical Co., Ltd. (Roche Shanghai Innovation Center), Shaoyuan Chemical Technology Co., Ltd., and Shandong Academy of Pharmaceutical Sciences. He has been engaged in innovative drug research and development and project management for a long time.
His major research has been on dopamine (D3) and serotonin (5-HT1A) agonists and tyrosine kinase inhibitors in the central nervous system. He has developed several drug molecules with potential biological activities for the central nervous system through a series of processes, such as homologous modeling, kinetic analysis, virtual screening, etc., using computer-aided drug design based on crystal structure. Some of his works have been published in J. Chem. Inf. Model, Curr Pharm Biotech, and other renowned publications. He has also participated in major new drug innovation and development projects in Shandong Province in the field of tyrosine kinase inhibitors, and several of the projects have been funded by Shandong Provincial Science and Technology Department and Shandong Provincial Natural Science Foundation Committee.

National Level II Human Resource Administrator
More than 10 years’ experience in human resource management and administration
Sun Xiaochen is highly proficient in human resources and administrative management, and has exceptional corporate management skills. She has previously worked in Foxconn Technology Group, Qicai Construction Group, and other well-known domestic enterprises. She has in-depth understanding and practical experience in human resource management and administrative management in modern enterprises; and has rich experience in establishing a robust human resource management system for startups.

Doctor of Genetics, University of California, USA
Postdoctoral Fellow in Biology, Stanford University, USA
Visiting Professor, School of Business, Hong Kong University of Science and Technology
As an entrepreneur and venture capitalist with rich experience in both the United States and China, Dr. Zhang Chaohui has experience working with top venture capital companies in Silicon Valley. He has founded three biotechnology companies in Silicon Valley, which have generated more than $200 million USD in returns for investors.

Professor of Qingdao University, National Outstanding Youth, Vice Minister of Medical Center, Dean of the Institute of Nerve Regeneration and Rehabilitation
Vice Minister of Medical Center, Vice Dean of Medical Research Institute, Vice Minister of Postgraduate Education and International Exchange of Wuhan University
Tenured Professor, University of Nevada, USA
Senior Scientist, University of Toronto, Canada
Wan Qi is the winner of the Canadian HSF and MRC Fellowship Awards and Canadian Research Foundation Awards. He has also published his works in Nature, Nature Neuroscience, Nature Medicine and other renowned publications, and has been invited to publish review articles in Trends in Neuroscience.